politics
Personalized mRNA vaccine shows promise in reducing melanoma return: Research
Why this matters: political developments that affect policy direction and public trust.
Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown promise in reducing the return of melanoma, the deadliest form of skin cancer. The findings were unearthed by researchers who tracked the impact of the vaccine five years after indi
Read full story on The Hill → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop